维普中文期刊产品整合服务
13篇 您的检索式:作者名="Nitz U"
    题名 作者 年代 出处 被引量
1Trastuzumab single-drug therapy after failure of cytotoxic treatment for metastatic breast cancer显示文摘Clemens M Eidtmann H Nitz U 2010Onkologie2010,33,89:1
2Quasi- simultaneous SIMS, AES, XPS, and TDMS Study of Preferential Sputtering, Diffusion, and Mercury Evaporation in CdxHgl_Te 显示文摘Nitz H M Ganschow O Kaiser U 1981Surface Science1981,104,23:1
3Triple- negative high -risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM -01 trial显示文摘Gluz O Nitz U A Harbeck N 2008Ann Oncol2008,19,5:1
4Triplenegative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy:results of WSG AM-01 trial显示文摘GLUZ O NITZ U A HARBECK N 2008Ann Oncol2008,19,5:1
5Comparison of rapidly cycled tandem high- dose chemotherapy plus peripheral-blood stem- cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase HI trial显示文摘NITZ U A MOHRMANN S FISCHER J 2005Lancet2005,366,9501:1
6Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial显示文摘Gluz O Nitz U A Harbeck N 2008Ann Oncol2008,19,5:1
7Retrospective analysis of WSGAM01 tandem high dose chemotherapy trial in high risk primary breast cancer:a hypothesis generating study显示文摘Nitz U A Gluz O Herr A 2006J Clin Oncol2006,24,18:1
8Surgical procedure after primary chemotherapy of breast carcinoma--an unresolved clinical problem 显示文摘Nitz U Rezai M Daubel A 2000Zentralbl Gynakol2000,122,5:1
9Final analysis of the prospective WSG- AGO EC-Doc versus FEC phase Ⅲ trial in intermediate-risk ( pN1 ) early breast cancer: efficacy and predictive value of Ki67 expression 显示文摘Nitz U Gluz O Huober J 2014Ann Oncol2014,25,8:1
10Trastuzumab single-drug therapy after failure of cytotoxic treatment for metas- tatic breast cancer显示文摘CLEMENS M EIDTMANN H NITZ U 2010Onkologie2010,33,89:1
11Surgical procedure after pri- mary chemotherapy of breast carcinoma--an unresolved clinical problem 显示文摘Nitz U Rezai M Daubel A 2000Zentralbl Gynakol2000,122,5:1
12Personalized treatment of ear-ly-stage breast cancer : present concepts and future directions显示文摘Harbeck N Salem M Nitz U 2010CancerTreat Rev2010,36,8:1
13Trastuzumab single-drug thera- py after failure of cytotoxic treatment for metastatic breast cancer显示文摘Clemens M Eidtmann H Nitz U 2010Onkologie2010,33,89:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费